People · Operator
Named in public records as an officer, director or promoter · active 2024–2026 · Biotechnology, Other Health Care, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Promaxo, Inc. | — | Biotechnology | Series C | $60.9M | $414.4M | 2024 |
| Particle Dynamics Holdings, Inc. | — | Other Health Care | Series B | $30.9M | $140.6M | 2025 |
| Promaxo Holdings, Inc. | — | Biotechnology | Series B | $26.8M | $92.0M | 2026 |
| Experic, LLC | — | Other | Series B | $15.0M | $88.5M | 2024 |
Derek Hennecke at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Derek Hennecke on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Amit Vohra | 2 | 3 |
| Matthew Reber | 2 | 3 |
| Michael Bartholomew | 2 | 2 |
| Dushyant Chipalkatty | 2 | 2 |
| David Wood | 1 | 8 |
| William Mitchell | 1 | 7 |
| Jonathan Chen | 1 | 3 |
| Shaun Kirkpatrick | 1 | 2 |
| Michael Caspani | 1 | 2 |
| Dan McCormick | 1 | 1 |
| Srirama Venkataraman | 1 | 1 |
| Nicolas Fortin | 1 | 1 |
| Michael Kanan | 1 | 1 |
| Thomas Weller | 1 | 1 |
| Andrew Frazier | 1 | 1 |
| Dinesh Kumar | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.